TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Brief Summary: The purpose of this study is to test the effectiveness of a DVD-delivered, home-based, six-month physical activity intervention for older adults.

A comparative effectiveness study of the FlexToBa DVD exercise program will be conducted in 2014.


Options:
A: Arm Label: FlexToBa physical activity DVD; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based, DVD-delivered physical activity | Arm Label: Usual care-Wait list; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care/Wait list | Intervention Type: BEHAVIORAL; Name: Home-based, DVD-delivered physical activity; Assigned to Arm(s): FlexToBa physical activity DVD | Intervention Type: BEHAVIORAL; Name: Usual care/Wait list; Assigned to Arm(s): Usual care-Wait list
B: Arm Label: Tailored Physical Activity Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Physical Activity Intervention | Arm Label: No Tailored Physical Activity Intervention Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored Physical Activity Intervention; Assigned to Arm(s): Tailored Physical Activity Intervention Group
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Mini Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Mini Booster | Arm Label: Full Booster; Type: EXPERIMENTAL; Interventions: Behavioral: Full Booster | Intervention Type: BEHAVIORAL; Name: Mini Booster; Assigned to Arm(s): Mini Booster | Intervention Type: BEHAVIORAL; Name: Full Booster; Assigned to Arm(s): Full Booster
D: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Brief Summary: The purpose of this study is to test the effectiveness of a DVD-delivered, home-based, six-month physical activity intervention for older adults.

A comparative effectiveness study of the FlexToBa DVD exercise program will be conducted in 2014.


Options:
A: Arm Label: Cognitive app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Social app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Affect app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Arm Label: Nutrition app; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford | Intervention Type: BEHAVIORAL; Name: Mobile Intervention for Lifestyle Eating/Exercise @ Stanford; Assigned to Arm(s): Affect app, Cognitive app, Nutrition app, Social app
B: Arm Label: FlexToBa physical activity DVD; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based, DVD-delivered physical activity | Arm Label: Usual care-Wait list; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care/Wait list | Intervention Type: BEHAVIORAL; Name: Home-based, DVD-delivered physical activity; Assigned to Arm(s): FlexToBa physical activity DVD | Intervention Type: BEHAVIORAL; Name: Usual care/Wait list; Assigned to Arm(s): Usual care-Wait list
C: Arm Label: Reduction in sitting time; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Arm Label: Increase in sit-to-stand transitions; Type: EXPERIMENTAL; Interventions: Behavioral: Sedentary behavior | Intervention Type: BEHAVIORAL; Name: Sedentary behavior; Assigned to Arm(s): Increase in sit-to-stand transitions, Reduction in sitting time
D: Arm Label: Wait list control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Monitor intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Monitor intervention | Intervention Type: BEHAVIORAL; Name: Monitor intervention; Assigned to Arm(s): Monitor intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Brief Summary: The purpose of this study is to test the effectiveness of a DVD-delivered, home-based, six-month physical activity intervention for older adults.

A comparative effectiveness study of the FlexToBa DVD exercise program will be conducted in 2014.


Options:
A: Arm Label: Tailored Physical Activity Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Physical Activity Intervention | Arm Label: No Tailored Physical Activity Intervention Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Tailored Physical Activity Intervention; Assigned to Arm(s): Tailored Physical Activity Intervention Group
B: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
C: Intervention Type: BEHAVIORAL; Name: Physical activity (PA) and immigrants; Assigned to Arm(s): N/A
D: Arm Label: FlexToBa physical activity DVD; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based, DVD-delivered physical activity | Arm Label: Usual care-Wait list; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care/Wait list | Intervention Type: BEHAVIORAL; Name: Home-based, DVD-delivered physical activity; Assigned to Arm(s): FlexToBa physical activity DVD | Intervention Type: BEHAVIORAL; Name: Usual care/Wait list; Assigned to Arm(s): Usual care-Wait list

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Activity, Gait, and Efficacy (AGE II): Functional Limitations and Quality of Life
Brief Summary: The purpose of this study is to test the effectiveness of a DVD-delivered, home-based, six-month physical activity intervention for older adults.

A comparative effectiveness study of the FlexToBa DVD exercise program will be conducted in 2014.


Options:
A: Intervention Type: BEHAVIORAL; Name: Physical activity (PA) and immigrants; Assigned to Arm(s): N/A
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Phone counseling with written materials | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Phone counseling with written materials; Assigned to Arm(s): Intervention Group
C: Arm Label: FlexToBa physical activity DVD; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based, DVD-delivered physical activity | Arm Label: Usual care-Wait list; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care/Wait list | Intervention Type: BEHAVIORAL; Name: Home-based, DVD-delivered physical activity; Assigned to Arm(s): FlexToBa physical activity DVD | Intervention Type: BEHAVIORAL; Name: Usual care/Wait list; Assigned to Arm(s): Usual care-Wait list
D: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma (TIVO-1)
Brief Summary: This is an open-label, randomized, controlled, multi-national, multi-center, parallel-arm trial comparing tivozanib to sorafenib in subjects with advanced RCC. The study is designed to compare the PFS, OS, ORR, DR, safety and tolerability, and kidney specific symptoms/health outcome measurements of tivozanib and sorafenib.


Options:
A: Arm Label: Savolitinib; Type: EXPERIMENTAL; Interventions: Drug: Savolitinib | Arm Label: Sunitinib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sunitinib | Intervention Type: DRUG; Name: Savolitinib; Assigned to Arm(s): Savolitinib | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): Sunitinib
B: Arm Label: A; Type: OTHER; Interventions: Drug: axitinib | Arm Label: B; Type: OTHER; Interventions: Drug: axitinib | Arm Label: C; Type: OTHER; Interventions: Drug: axitinib | Intervention Type: DRUG; Name: axitinib; Assigned to Arm(s): A | Intervention Type: DRUG; Name: axitinib; Assigned to Arm(s): B | Intervention Type: DRUG; Name: axitinib; Assigned to Arm(s): C
C: Arm Label: Sunitinib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sunitinib | Arm Label: Pazopanib; Type: EXPERIMENTAL; Interventions: Drug: Pazopanib | Intervention Type: DRUG; Name: Pazopanib; Assigned to Arm(s): Pazopanib | Intervention Type: DRUG; Name: Sunitinib; Assigned to Arm(s): Sunitinib
D: Arm Label: tivozanib (AV-951); Type: EXPERIMENTAL; Interventions: Drug: tivozanib (AV-951) | Arm Label: sorafenib; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sorafenib | Intervention Type: DRUG; Name: tivozanib (AV-951); Assigned to Arm(s): tivozanib (AV-951) | Intervention Type: DRUG; Name: Sorafenib; Assigned to Arm(s): sorafenib

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Controlled Trial of a Treatment Algorithm for the Management of Crohn's Disease
Brief Summary: Assess if the implementation of a treatment algorithm will improve the management of Crohn's disease (CD) in comparison to usual care based gastroenterology practices.


Options:
A: Arm Label: Usual Care practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Algorithm; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Algorithm for Crohn's Disease | Intervention Type: OTHER; Name: Treatment Algorithm for Crohn's Disease; Assigned to Arm(s): Treatment Algorithm
B: Arm Label: CT-P13; Type: EXPERIMENTAL; Interventions: Drug: Biosimilar infliximab | Arm Label: INX; Type: ACTIVE_COMPARATOR; Interventions: Drug: Innovator infliximab | Intervention Type: DRUG; Name: Innovator infliximab; Assigned to Arm(s): INX | Intervention Type: DRUG; Name: Biosimilar infliximab; Assigned to Arm(s): CT-P13
C: Arm Label: 003; Type: EXPERIMENTAL; Interventions: Other: infliximab (IFX) infusion; azathioprine (AZA) caps | Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: infliximab (IFX) placebo infusion; azathioprine (AZA) caps | Arm Label: 002; Type: EXPERIMENTAL; Interventions: Biological: infliximab infusion; AZA placebo caps | Intervention Type: BIOLOGICAL; Name: infliximab infusion; AZA placebo caps; Assigned to Arm(s): 002 | Intervention Type: OTHER; Name: infliximab (IFX) infusion; azathioprine (AZA) caps; Assigned to Arm(s): 003 | Intervention Type: DRUG; Name: infliximab (IFX) placebo infusion; azathioprine (AZA) caps; Assigned to Arm(s): 001
D: Arm Label: INFLIXIMAB AND ANTI METABOLITE; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: STOP INFLIXIMAB CONTINUING ANTI METABOLITE; Type: OTHER; Interventions: Drug: INFLIXIMAB | Arm Label: CONTINUING INFLIXIMAB AND discontinuing anti-metabolites; Type: OTHER; Interventions: Drug: AZATHIOPRINE, Drug: MERCAPTOPURINE, Drug: Methotrexate | Intervention Type: DRUG; Name: INFLIXIMAB; Assigned to Arm(s): STOP INFLIXIMAB CONTINUING ANTI METABOLITE | Intervention Type: DRUG; Name: AZATHIOPRINE; Assigned to Arm(s): CONTINUING INFLIXIMAB AND discontinuing anti-metabolites | Intervention Type: DRUG; Name: MERCAPTOPURINE; Assigned to Arm(s): CONTINUING INFLIXIMAB AND discontinuing anti-metabolites | Intervention Type: DRUG; Name: Methotrexate; Assigned to Arm(s): CONTINUING INFLIXIMAB AND discontinuing anti-metabolites

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Controlled Trial of a Treatment Algorithm for the Management of Crohn's Disease
Brief Summary: Assess if the implementation of a treatment algorithm will improve the management of Crohn's disease (CD) in comparison to usual care based gastroenterology practices.


Options:
A: Arm Label: Usual Care practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Algorithm; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Algorithm for Crohn's Disease | Intervention Type: OTHER; Name: Treatment Algorithm for Crohn's Disease; Assigned to Arm(s): Treatment Algorithm
B: Arm Label: Active arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: endoscopy | Arm Label: Standard care arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: endoscopy; Assigned to Arm(s): Active arm
C: Arm Label: DB Adalimumab 40 mg eow; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Arm Label: Placebo eow; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: OL Adalimumab 40 mg eow; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Intervention Type: BIOLOGICAL; Name: adalimumab; Assigned to Arm(s): DB Adalimumab 40 mg eow, OL Adalimumab 40 mg eow | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo eow
D: Arm Label: Adalimumab 160 mg/80 mg; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Arm Label: Adalimumab 80 mg/40 mg; Type: EXPERIMENTAL; Interventions: Biological: adalimumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: placebo | Intervention Type: BIOLOGICAL; Name: adalimumab; Assigned to Arm(s): Adalimumab 160 mg/80 mg | Intervention Type: BIOLOGICAL; Name: adalimumab; Assigned to Arm(s): Adalimumab 80 mg/40 mg | Intervention Type: BIOLOGICAL; Name: placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Cluster Randomized Controlled Trial of a Treatment Algorithm for the Management of Crohn's Disease
Brief Summary: Assess if the implementation of a treatment algorithm will improve the management of Crohn's disease (CD) in comparison to usual care based gastroenterology practices.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: infliximab+azathioprine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: methylprednisolone or budesonide | Intervention Type: DRUG; Name: infliximab+azathioprine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: methylprednisolone or budesonide; Assigned to Arm(s): 2
B: Arm Label: Usual Care practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Treatment Algorithm; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment Algorithm for Crohn's Disease | Intervention Type: OTHER; Name: Treatment Algorithm for Crohn's Disease; Assigned to Arm(s): Treatment Algorithm
C: Arm Label: Therapeutic drug monitoring; Type: EXPERIMENTAL; Interventions: Other: Therapeutic drug monitoring | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Therapeutic drug monitoring; Assigned to Arm(s): Therapeutic drug monitoring | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: CT-P13 - CT-P13; Type: EXPERIMENTAL; Interventions: Biological: CT-P13 | Arm Label: CT-P13 - Remicade; Type: ACTIVE_COMPARATOR; Interventions: Biological: CT-P13, Biological: Remicade | Arm Label: Remicade - Remicade; Type: ACTIVE_COMPARATOR; Interventions: Biological: Remicade | Arm Label: Remicade - CT-P13; Type: EXPERIMENTAL; Interventions: Biological: CT-P13, Biological: Remicade | Intervention Type: BIOLOGICAL; Name: CT-P13; Assigned to Arm(s): CT-P13 - CT-P13, CT-P13 - Remicade, Remicade - CT-P13 | Intervention Type: BIOLOGICAL; Name: Remicade; Assigned to Arm(s): CT-P13 - Remicade, Remicade - CT-P13, Remicade - Remicade

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Shared Decision-Making for Elderly Depressed Primary Care Patients
Brief Summary: Shared decision-making (SDM), in contrast to traditional medical decision-making, involves a collaborative process where patients discuss personal values and preferences and clinicians provide information to arrive at an agreed upon treatment decision. The proposed study will evaluate the impact of a brief SDM nursing intervention among elderly, depressed primary care patient subjects in comparison to physician recommended Usual Care. The focus of the SDM intervention is to empower depressed patients and help them arrive at a treatment decision that can be successfully carried out.


Options:
A: Arm Label: MOMCare intervention; Type: EXPERIMENTAL; Interventions: Behavioral: MOMCare | Arm Label: Care Plus; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MOMCare; Assigned to Arm(s): MOMCare intervention
B: Arm Label: Shared Decision Making; Type: EXPERIMENTAL; Interventions: Behavioral: Shared Decision Making | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Shared Decision Making; Assigned to Arm(s): Shared Decision Making | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
C: Arm Label: SDM care planning; Type: EXPERIMENTAL; Interventions: Other: Shared Decision-Making educational training | Intervention Type: OTHER; Name: Shared Decision-Making educational training; Assigned to Arm(s): SDM care planning
D: Arm Label: Collaborative Decision Skills Training; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Decision Skills Training | Arm Label: Leveling Up; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Leveling Up | Intervention Type: BEHAVIORAL; Name: Collaborative Decision Skills Training; Assigned to Arm(s): Collaborative Decision Skills Training | Intervention Type: BEHAVIORAL; Name: Leveling Up; Assigned to Arm(s): Leveling Up

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 24-week, Multicentre, Randomised, Double-blind, Age-stratified, Placebo Controlled, Phase III Study With a 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Pts With T2DM, CV Disease and Hypertension Who Exhibit Inadequate Glycaemic Control on Usual Care
Brief Summary: This study is carried out to assess whether dapagliflozin lowers blood glucose, body weight and blood pressure, when added to patients existing medications and how it compares with their usual treatment without added dapagliflozin. Safety data will be collected and analysed to confirm that treatment with dapagliflozin is safe and well tolerated in patients who have diabetes, cardiovascular disease and hypertension.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Dapagliflozin | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dapagliflozin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Saxagliptin; Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Saxagliptin; Assigned to Arm(s): Saxagliptin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lenograstim (GRANOCYTE)=GCSF, Drug: Sitagliptin (Januvia) | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride (NaCl) 0.9 %, Drug: Gelatin | Intervention Type: DRUG; Name: Lenograstim (GRANOCYTE)=GCSF; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sitagliptin (Januvia); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sodium Chloride (NaCl) 0.9 %; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Gelatin; Assigned to Arm(s): 2
D: Arm Label: BI 10773 low dose; Type: EXPERIMENTAL; Interventions: Drug: BI 10773 low dose, Drug: Placebo BI 10773 high dose | Arm Label: BI 10773 high dose; Type: EXPERIMENTAL; Interventions: Drug: BI 10773 high dose, Drug: Placebo BI 10773 low dose | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo BI 10773 high dose, Drug: Placebo BI 10773 low dose | Intervention Type: DRUG; Name: BI 10773 low dose; Assigned to Arm(s): BI 10773 low dose | Intervention Type: DRUG; Name: Placebo BI 10773 high dose; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: BI 10773 high dose; Assigned to Arm(s): BI 10773 high dose | Intervention Type: DRUG; Name: Placebo BI 10773 low dose; Assigned to Arm(s): BI 10773 high dose | Intervention Type: DRUG; Name: Placebo BI 10773 low dose; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo BI 10773 high dose; Assigned to Arm(s): BI 10773 low dose

Answer: A